BBNX — Beta Bionics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1674632 ·
Last close
$19.73
Market Cap
$887.65M
52W High
$20.74
52W Low
$11.26
ADV30
1,367,366
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 32,013,000 | 18,902,000 | -25,578,000 | -23,403,000 | 292,387,000 | 44,318,000 | 36,021,000 |
| Mar 2026 | 27,626,000 | 16,437,000 | -24,271,000 | -21,895,000 | 304,417,000 | 30,206,000 | 33,172,000 |
| Dec 2025 | 32,121,000 | 18,944,000 | -16,124,000 | -13,466,000 | 328,743,000 | 31,576,000 | 41,133,000 |
| Sep 2025 | 27,253,000 | 15,119,000 | -17,043,000 | -14,209,000 | 330,046,000 | 38,485,000 | 35,286,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-55,810,000
Investing CF
$58,916,000
Financing CF
$6,137,000
CapEx
$-5,601,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.65
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-415,235,000
Inventory
$23,918,000
Receivables
$20,252,000
ST Investments
$136,171,000
EBIT TTM
$-78,840,000
Pretax Income TTM
$-72,973,000
Interest Exp TTM
—
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$119,013,000
EBITDA
$-80,799,000
Free Cash Flow
$-40,294,000
Enterprise Value
$713,669,568
Total Cash
$180,488,992
Total Debt
$6,512,000
Shares Out
44,989,688
Trailing EPS
$-1.66
Book Value
$5.70
ROE
-26.2%
ROA
-16.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 100,251,000 | -71,681,000 | -73,200,000 | 328,743,000 | 41,133,000 | — | -50,925,000 |
| Dec 2024 | 65,124,000 | -45,251,000 | -54,756,000 | 149,645,000 | 395,005,000 | — | -48,273,000 |
| Dec 2023 | 11,995,000 | -35,850,000 | -44,099,000 | 110,040,000 | 313,145,000 | — | -32,445,000 |
| Dec 2022 | 179,000 | -65,844,000 | -64,751,000 | 35,527,000 | 205,561,000 | — | -60,208,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.31
Max Pain — expiry 2027-01-15
max pain strike: $10.00 · spot: $19.73 · call oi: 1,137 · put oi: 0Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | $878.34M | $26.26 | — |
| INMD | InMode Ltd. | $868.92M | $15.10 | — |
| SIBN | SI-BONE, Inc. | $863.48M | $19.47 | — |
| CBLL | Ceribell, Inc. | $918.77M | $23.94 | — |
| AVR | Anteris Technologies Global Corp. | $856.61M | $8.80 | — |
News headlines (Yahoo Finance, 1h cache)
Beta Bionics (BBNX) Q2 2026 Earnings Call Transcript
2026-08-08 01:14 · Yahoo
Beta Bionics (BBNX) Stock Fair Value Falls As Medtech Reset Tempers iLet And Mint Optimism
2026-07-25 20:06 · Yahoo
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
2026-07-01 12:30 · Yahoo
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
2026-06-02 13:00 · Yahoo
Beta Bionics to launch its first insulin patch pump to compete with Insulet
2026-05-26 10:15 · Yahoo
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
2026-05-21 20:04 · Yahoo
Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
2026-05-13 06:05 · Yahoo
Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation
2026-05-12 12:03 · Yahoo
Beta Bionics to Present at the Bank of America Securities Health Care Conference
2026-04-27 20:25 · Yahoo
Beta Bionics, Inc. Q1 2026 Earnings Call Summary
2026-04-22 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.